RxDoctor Payments Data

Joseph Fountain, DO

Family Medicine · Milton, FLNPI 1225042864

Payments from drug & device makers

$5,945in general payments, 2019–2025

Across 382 payments — averaging $15.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$987
  • AbbVie$612
  • GSK$562
  • Pfizer$470
  • Amgen$439
  • Lilly USA, LLC$402
  • plus $2K from 34 others

What the payments were for

  • Food & beverage$5,88499%
  • Education$611%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,945 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$189,429
Medicare patients
412
Services billed
3,155

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol40$41,149
TrulicityDulaglutide29$40,749
JanuviaSitagliptin Phosphate30$30,770
EliquisApixaban31$21,053
JardianceEmpagliflozin29$20,285
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$15,177
OzempicSemaglutide11$12,197
NamzaricMemantine Hcl/Donepezil Hcl22$6,322
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog14$5,813
Atorvastatin Calcium370$5,008
Rosuvastatin Calcium244$4,050
LantusInsulin Glargine,hum.Rec.Anlog15$3,872
Gabapentin102$2,987
Lisinopril260$2,394
Losartan Potassium185$1,932

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$384$41,14940 claims
Lilly USA, LLCTrulicity$402$40,74929 claims
MerckJanuvia$121$30,77030 claims
PfizerEliquis$470$21,05331 claims
Boehringer IngelheimJardiance$165$20,28529 claims
GSKTrelegy Ellipta$562$15,17721 claims
Novo NordiskOzempic$987$12,19711 claims
AbbVieNamzaric, Synthroid$612$7,40655 claims
Sanofi-aventis U.S. LLCLantus$46$3,87215 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Milton

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →